drugset / Trial / NCT03185481
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the long term safety and tolerability of PF-06649751 in Parkinson's disease patients who experience motor-fluctuations.
Timeline
- Start
- 2017-07-06
- Primary completion
- 2017-10-24
- Completion
- 2017-10-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavapadon | Small molecule | 7 mg | — |
| Subject | Tavapadon | Small molecule | 15 mg | — |